| Literature DB >> 20727996 |
Paulina Wyrzykowska1, Krystyna Stalińska, Mateusz Wawro, Jakub Kochan, Aneta Kasza.
Abstract
PAI-1 (plasminogen activator inhibitor-1) in breast cancer cells is involved in tumour development and metastasis of breast cancer cells. PAI-1 function and the regulation of its expression have been precisely investigated. Here we report that EGF, which promotes breast cancer tumour growth and survival, rapidly induces PAI-1 expression in the breast adenocarcinoma cell line MCF-7 through the activation of the transcription factor Elk-1. We have found that the PAI-1 promoter fragment (-140 to +173) containing the Ets consensus binding site is activated by Elk-1. Chromatin immunoprecipitation analysis confirms in vivo binding of Elk-1 to the PAI-1 promoter and demonstrates that Elk-1 phosphorylation on the Ets binding site is EGF-dependent.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20727996 DOI: 10.1016/j.bbagrm.2010.08.004
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002